ArticlePharmacoEconomics2004

Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.

Andrew Moore et al.PubMed ↗Publisher ↗

No numbers read from the abstract.